HealthEquity Appoints New Chief Legal Officer

Ticker: HQY · Form: 8-K · Filed: Apr 25, 2024 · CIK: 1428336

Healthequity, INC. 8-K Filing Summary
FieldDetail
CompanyHealthequity, INC. (HQY)
Form Type8-K
Filed DateApr 25, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, legal, compensation

Related Tickers: HQY

TL;DR

HealthEquity names Michelle Johnson as new CLO, starting May 6th. Salary $375k.

AI Summary

On April 25, 2024, HealthEquity, Inc. announced the appointment of Michelle L. Johnson as Chief Legal Officer and General Counsel, effective May 6, 2024. Johnson will receive an annual base salary of $375,000 and will be eligible for equity awards and other standard benefits. She previously served as General Counsel and Corporate Secretary at HealthEquity.

Why It Matters

The appointment of a new Chief Legal Officer can impact the company's legal strategy, compliance, and risk management. Michelle Johnson's prior experience at HealthEquity suggests a smooth transition and continued focus on legal matters.

Risk Assessment

Risk Level: low — This filing primarily concerns an executive appointment and compensation, which is a routine corporate event with limited immediate financial risk.

Key Numbers

Key Players & Entities

FAQ

Who has been appointed as the new Chief Legal Officer and General Counsel for HealthEquity, Inc.?

Michelle L. Johnson has been appointed as the new Chief Legal Officer and General Counsel for HealthEquity, Inc.

When is Michelle L. Johnson's appointment as Chief Legal Officer effective?

Michelle L. Johnson's appointment is effective May 6, 2024.

What is Michelle L. Johnson's annual base salary?

Michelle L. Johnson's annual base salary is $375,000.

What was Michelle L. Johnson's previous role at HealthEquity?

Michelle L. Johnson previously served as General Counsel and Corporate Secretary at HealthEquity.

What other compensation is Michelle L. Johnson eligible for?

Michelle L. Johnson will be eligible for equity awards and other standard benefits.

Filing Stats: 517 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2024-04-25 16:02:01

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (formatted in Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: April 25, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing